Sign up to save your podcasts
Or
Share “Taking possibility back” across oncology’s toughest frontiers
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
“Taking possibility back” across oncology’s toughest frontiers
What does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead
Sciences, shares how the company is tackling urgent needs in triple negative breast cancer (TNBC) and pioneering the next generation of CAR-T therapies to reshape what’s possible in oncology.
Read more: https://www.statnews.com/sponsor/2025/10/09/taking-possibility-back-across-oncologys-toughest-frontiers/
Photo: Radhika Patnala/Endosymbiont GmBH
View all episodes
By STAT Brand StudioWhat does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead
Sciences, shares how the company is tackling urgent needs in triple negative breast cancer (TNBC) and pioneering the next generation of CAR-T therapies to reshape what’s possible in oncology.
Read more: https://www.statnews.com/sponsor/2025/10/09/taking-possibility-back-across-oncologys-toughest-frontiers/
Photo: Radhika Patnala/Endosymbiont GmBH